Versartis
Develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD300—450m (Dealroom.co estimates Feb 2014.)
Menlo Park California (HQ)
Authorizing premium user...